During the past decade, The Institute of Ophthalmology and Visual Science (IOVS) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Institute of Ophthalmology and Visual Science (IOVS)" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "The Institute of Ophthalmology and Visual Science (IOVS)" are "Diabetic Macular Edema" (3 trials), "Eyes Without Ocular Pathology" (1 trials) and "Normal Eyes and Eyes With Ocular Pathologies" (1 trials). Many other conditions were trialed in "The Institute of Ophthalmology and Visual Science (IOVS)" in a lesser frequency.

Most popular intervention types in "The Institute of Ophthalmology and Visual Science (IOVS)" are "Drug" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "SD-OCT" (2 trials), "0.3 mg intravitreal ranibizumab" (1 trials), "1.25 mg intravitreal bevacizumab" (1 trials), "2.0 mg intravitreal aflibercept" (1 trials) and "Deferred aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Institute of Ophthalmology and Visual Science (IOVS)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "The Institute of Ophthalmology and Visual Science (IOVS)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Institute of Ophthalmology and Visual Science (IOVS), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Institute of Ophthalmology and Visual Science (IOVS), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".